Gene · 28884
IGKV2D-26: immunoglobulin kappa variable 2D-26
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. IGKV2D-26: immunoglobulin kappa variable 2D-26. Genes, record 28884. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/28884
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| A0A0A0MRZ7 | Immunoglobulin kappa variable 2D-26 | 120 | 0 | Ensembl, HGNC |
Source UniProt
Patents5
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,572
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IGKV2D-26 papers | Newest fiscal year |
|---|---|---|---|
| R01DK018381 | Studies on the structure of basement membranes | 19 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA023074 | University of Arizona Cancer Center - Cancer Center Support Grant | 6 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 6 | 2025 |
| R01CA212608 | Probing RAS-mediated Signaling with Monobody Inhibitors | 6 | 2025 |
| R01HL131836 | Structural Transition of Cellular Integrins and Applications Thereof | 6 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 5 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
1 to 10 of 2,572Source NIH's project files
See all 2,572 nih grantsPapers3,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GABAA receptor α subunit distribution is congruent with functional anatomical areas in the human cortex. | J Cereb Blood Flow Metab | 2026 | 42802645 | PubTator, text mining | PubMed |
| Lymph node extracellular matrix skews the immune function of human fibroblastic reticular cells. | iScience | 2026 | 42780986 | PubTator, text mining | PubMed |
| Targeting α5-GABAA receptors to restore dopamine system function in a translationally relevant model of perimenopausal psychosis. | Psychopharmacology (Berl) | 2026 | 42776198 | PubTator, text mining | PubMed |
| Structural basis for activation and potentiation in a human α5β3 GABAA receptor. | Nat Commun | 2026 | 42297817 | PubTator, text mining | PubMed |
| Alterations in the Components of the GABA-Glutamate System During ZIKV Infection: A Neuroscience Approach. | Int J Mol Sci | 2026 | 42278369 | PubTator, text mining | PubMed |
| Targeting the H/KRAS α4-β6-α5 Allosteric Lobe with Macrocyclic Peptides. | ACS Med Chem Lett | 2026 | 42157834 | PubTator, text mining | PubMed |
| Structural and mechanistic insights into α2β1 and α5β1 integrin targeting by bioengineered extracellular vesicles originating from lung cancer cells. | Sci Rep | 2026 | 41896296 | PubTator, text mining | PubMed |
| Ligand-specific conformational dynamics of the α2A-adrenergic receptor revealed by hydrogen-deuterium exchange mass spectrometry. | Structure | 2026 | 41812653 | PubTator, text mining | PubMed |
| Polystyrene Nanoparticles Disrupt Oxidative Phosphorylation and Impair Placental Development in Mice. | Toxics | 2026 | 41745832 | PubTator, text mining | PubMed |
The β-amyloid-induced increased tonic conductance, impaired long-term potentiation and cognitive deficits characteristic of Alzheimer's disease are reversed by an α5 inverse agonist of the GABA type A receptor. | Neuropharmacology | 2026 | 41740903 | PubTator, text mining | PubMed |
1 to 10 of 3,317
See all 3,317 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/28884
GET https://conductscience.org/api/genes/v1/28884/grants?page=2